Australian Full Federal Court clarifies best method disclosure obligation in Pfizer v Eli Lilly appeal

The Australian Full Federal Court has found that (i) a patentapplicant may amend the patent specification, until at leastthe date of grant, to include the best method known to the applicantat the date of filing and that (ii) there is no requirementthat new best methods discovered after the date of filing ofa complete patent specification be added by amendment.